Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes

被引:17
|
作者
El-Ashmawy, Hazem M. [1 ]
Ahmed, Azza M. [2 ]
机构
[1] Zagazig Univ, Fac Med, Dept Internal Med, Zagazig, Egypt
[2] Zagazig Univ, Fac Med, Dept Clin Pathol, Zagazig, Egypt
关键词
fetuin-B; nonalcoholic fatty liver disease; type 2 diabetes mellitus; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; A LEVELS; RISK; ATHEROSCLEROSIS; STEATOHEPATITIS; INFLAMMATION; ASSOCIATION; GLUCOSE;
D O I
10.1097/MEG.0000000000001354
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective Previous studies have assessed serum fetuin-B and its relation to nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) and as a link between them through inducing insulin resistance (IR). Therefore, we examined the potential of serum fetuin-B to be an independent marker for NAFLD in patients with T2DM. Patients and methods The study group consisted of 270 patients with T2DM. Clinical and laboratory features were evaluated. The NAFLD severity was graded by ultrasound into three subgroups: grade 0 (no fatty liver), grade 1 (mild fatty liver), and grade 2-3 (medium to severe fatty liver). Fetuin-B, retinol-binding protein-4, and adiponectin were measured. Results Patients with grade 2-3 NAFLD had high fetuin-B levels in comparison with non-NAFLD group. Age and sex adjusted fetuin-B demonstrated positive correlations with triglycerides, gamma-glutamyl transferase, fasting plasma glucose, 2-h postprandial plasma glucose, homeostasis model assessment of IR, fasting insulin, glycated hemoglobin, high-sensitivity C-reactive protein, and estimated glomerular filtration rate, but it had a negative correlation with serum creatinine. Adiponectin level was decreased with increasing NAFLD severity, but no difference was found in retinol-binding protein-4. The estimated odds ratio (OR) for the occurrence of grade 2-3 NAFLD was increased significantly with increasing levels of fetuin-B (OR: 3.92; 95% confidence interval: 2.14-8.32 vs. OR: 8.91; 95% confidence interval: 4.22-18.41). The OR of fetuin-B in the uppermost tertile group was still significant after controlling for homeostasis model assessment of IR, glycated hemoglobin, waist circumference, BMI, hepatic enzymes, high-density lipoprotein cholesterol, triglycerides, and high-sensitivity C-reactive protein. Conclusions Our study demonstrated that serum fetuin-B had an independent association with NAFLD in patients with T2DM.
引用
收藏
页码:859 / 864
页数:6
相关论文
共 50 条
  • [41] Nonalcoholic fatty liver disease is a risk factor for CKD in patients with type 2 diabetes
    不详
    Nature Clinical Practice Nephrology, 2008, 4 (11): : 584 - 584
  • [42] Fasting Hyperglucagonemia in Patients with Nonalcoholic Fatty Liver Disease With and Without Type 2 Diabetes
    Junker, Anders E.
    Gluud, Lise L.
    Holst, Jens J.
    Knop, Filip K.
    Vils-Boll, Tina
    DIABETES, 2014, 63 : A467 - A467
  • [43] Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease
    Mantovani, Alessandro
    Pernigo, Matteo
    Bergamini, Corinna
    Bonapace, Stefano
    Lipari, Paola
    Valbusa, Filippo
    Bertolini, Lorenzo
    Zenari, Luciano
    Pichiri, Isabella
    Dauriz, Marco
    Zoppini, Giacomo
    Barbieri, Enrico
    Byrne, Christopher D.
    Bonora, Enzo
    Targher, Giovanni
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (08): : 879 - 887
  • [44] Nonalcoholic fatty liver disease is a risk factor for CKD in patients with type 2 diabetes
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 (11): : 593 - 593
  • [45] Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosis
    Cengiz, Mustafa
    Ozenirler, Seren
    Kocabiyik, Murat
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (01) : 57 - 63
  • [46] Serum zinc level and liver fibrosis in male patients with nonalcoholic fatty liver disease
    Sohn, Won
    Kim, Jung Hee
    Cho, Ju-Yeon
    Jeong, Jae Yoon
    Kim, Hong Joo
    Cho, Yong Kyun
    Kim, Byung Ik
    JOURNAL OF HEPATOLOGY, 2020, 73 : S151 - S151
  • [47] Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes
    Yamazaki, Hajime
    Tsuboya, Toru
    Tsuji, Kunihiko
    Dohke, Mitsuru
    Maguchi, Hiroyuki
    DIABETES CARE, 2015, 38 (09) : 1673 - 1679
  • [48] Leptin is an independent marker of liver fibrosis in humans with nonalcoholic fatty liver disease
    Alba, LM
    Petrovic, L
    Lindor, KD
    Talwalkar, JA
    Angulo, P
    HEPATOLOGY, 2002, 36 (04) : 296A - 296A
  • [49] Association between serum uric acid and nonalcoholic fatty liver disease in community patients with type 2 diabetes mellitus
    Xu, Linxin
    Li, Ting
    Yin, Jianhong
    Lin, Gang
    Xu, Yali
    Ren, Yi
    Wang, Yan
    Yang, Jing
    Chen, Liming
    PEERJ, 2019, 7
  • [50] Increased Serum Pentraxin 3 Is Associated with Prediabetes and Type 2 Diabetes in Obese Patients with Nonalcoholic Fatty Liver Disease
    Karamfilova, Vera
    Assyov, Yavor
    Nedeva, Iveta
    Gateva, Antoaneta
    Ivanova, Irena
    Cherkezov, Nikolay
    Mateva, Ludmila
    Kamenov, Zdravko
    METABOLIC SYNDROME AND RELATED DISORDERS, 2022, 20 (02) : 132 - 136